Vycor Medical, Inc. (VYCO)
OTCMKTS
· Delayed Price · Currency is USD
0.1150
+0.0150 (15.00%)
Jun 13, 2025, 1:52 PM EDT
Vycor Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 1.69 | 1.59 | 1.46 | 1.22 | 1.39 | 1.14 | Upgrade
|
| Revenue Growth (YoY) | 17.55% | 8.81% | 19.43% | -12.20% | 21.97% | -18.01% | Upgrade
|
| Cost of Revenue | 0.21 | 0.17 | 0.14 | 0.14 | 0.13 | 0.13 | Upgrade
|
| Gross Profit | 1.48 | 1.42 | 1.32 | 1.08 | 1.26 | 1.01 | Upgrade
|
| Selling, General & Admin | 1.41 | 1.36 | 1.2 | 1.33 | 1.61 | 1.68 | Upgrade
|
| Research & Development | 0.02 | 0.02 | 0.02 | - | 0.02 | - | Upgrade
|
| Operating Expenses | 1.49 | 1.43 | 1.28 | 1.39 | 1.69 | 1.74 | Upgrade
|
| Operating Income | -0.01 | -0.01 | 0.04 | -0.31 | -0.44 | -0.73 | Upgrade
|
| Interest Expense | -0.1 | -0.1 | -0.1 | -0.09 | -0.09 | -0.08 | Upgrade
|
| Currency Exchange Gain (Loss) | -0 | -0 | -0 | -0 | -0 | -0 | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | 0.01 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -0.11 | -0.11 | -0.06 | -0.4 | -0.53 | -0.81 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.12 | 0.01 | Upgrade
|
| Pretax Income | -0.11 | -0.11 | -0.06 | -0.4 | -0.41 | -0.8 | Upgrade
|
| Earnings From Continuing Operations | -0.11 | -0.11 | -0.06 | -0.4 | -0.41 | -0.8 | Upgrade
|
| Earnings From Discontinued Operations | -0 | -0 | -0.01 | -0.01 | -0.03 | -0.02 | Upgrade
|
| Net Income | -0.12 | -0.11 | -0.07 | -0.4 | -0.44 | -0.82 | Upgrade
|
| Preferred Dividends & Other Adjustments | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | Upgrade
|
| Net Income to Common | -0.44 | -0.43 | -0.39 | -0.73 | -0.76 | -1.15 | Upgrade
|
| Shares Outstanding (Basic) | 33 | 33 | 33 | 32 | 30 | 26 | Upgrade
|
| Shares Outstanding (Diluted) | 33 | 33 | 33 | 32 | 30 | 26 | Upgrade
|
| Shares Change (YoY) | 1.35% | 0.86% | 2.83% | 7.02% | 13.51% | 8.94% | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | -0.01 | -0.02 | -0.03 | -0.04 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.02 | -0.03 | -0.04 | Upgrade
|
| Free Cash Flow | 0.03 | 0.06 | 0.02 | -0.22 | -0.02 | -0.31 | Upgrade
|
| Free Cash Flow Per Share | 0.00 | 0.00 | 0.00 | -0.01 | -0.00 | -0.01 | Upgrade
|
| Gross Margin | 87.70% | 89.50% | 90.08% | 88.50% | 90.33% | 88.40% | Upgrade
|
| Operating Margin | -0.73% | -0.57% | 2.75% | -25.06% | -31.30% | -63.69% | Upgrade
|
| Profit Margin | -26.03% | -27.15% | -26.98% | -59.63% | -54.56% | -100.42% | Upgrade
|
| Free Cash Flow Margin | 1.61% | 3.52% | 1.37% | -17.97% | -1.22% | -27.22% | Upgrade
|
| EBITDA | 0.05 | 0.05 | 0.1 | -0.25 | -0.37 | -0.67 | Upgrade
|
| EBITDA Margin | 3.08% | 3.45% | 6.91% | -20.04% | -26.38% | -58.62% | Upgrade
|
| D&A For EBITDA | 0.06 | 0.06 | 0.06 | 0.06 | 0.07 | 0.06 | Upgrade
|
| EBIT | -0.01 | -0.01 | 0.04 | -0.31 | -0.44 | -0.73 | Upgrade
|
| EBIT Margin | -0.73% | -0.57% | 2.75% | -25.06% | -31.30% | -63.69% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.